Pain Management Clinic in London: Minimally Invasive Options for Spinal Chronic Pain
Struggling with persistent spinal pain can feel like life is on pause. The good news? Minimally invasive day surgeries and targeted injections are helping many people reclaim movement without major operations or prolonged recovery. At our Pain Management Clinic in London, we see this every week—particularly with carefully selected patients who benefit from spinal cord stimulation (SCS) and precision-guided injections as part of a personalised care plan.
What Is Spinal Cord Stimulation—and Who Might Benefit?
Spinal cord stimulation (SCS) is a minimally invasive therapy where a small device delivers gentle electrical pulses to the spinal cord, aiming to reduce pain signals. It’s most commonly considered for persistent spinal pain syndrome—Type 2 (PSPS-T2), historically called failed back surgery syndrome, when significant pain continues after prior spinal surgery despite conservative care.
In practice, SCS starts with a temporary “trial” to assess response. If pain relief is meaningful—often defined as around 50% improvement—patients may proceed to a permanent implant. It’s a day-surgery or short-stay procedure for most patients, with recovery typically measured in days rather than weeks.
Latest Evidence: How Effective Is SCS for PSPS-T2?
A recent systematic review of randomised controlled trials (RCTs) assessed dorsal column SCS for PSPS-T2, comparing it with conventional medical management (CMM) or sham stimulation. Out of 1,988 publications screened, six RCTs involving 448 participants met inclusion criteria, with 220 ultimately receiving SCS implants. The review concluded there is moderate-quality evidence that SCS reduces pain and disability at six months in appropriately selected patients (PubMed; PMC; DOI).
Key outcomes at a glance
Across studies with follow-up from 1 month to 2 years:
- Pain relief of at least 50%: 14%–80% with tonic SCS vs 3%–20% with CMM.
- Average pain reduction at 1–6 months: 16%–48% (tonic SCS), 16%–17% (burst SCS), −15% to 16% (CMM), 10%–16% (sham).
- Functional improvement at 6 months: 21%–45% (tonic SCS) vs 0%–21% (CMM).
Notably, the only sham-controlled study did not show efficacy for burst SCS, and newer closed-loop or high-frequency systems were not included—so future studies may shift the picture as technology advances.
Risks and Adverse Events: What Should Patients Know?
Like any procedure, SCS can have complications. Reported rates varied across studies, with more recent trials tending to report fewer issues. Recorded events included:
- Lead migration: 10%–14%
- Implantable pulse generator (IPG) site pain: 1%–12%
- Infection: 6.9%–10%
- Dural puncture: around 6%
Risk reduction strategies include meticulous sterile technique, pre-operative screening, modern anchoring methods, and close follow-up. We discuss individual risk profiles during consultation and ensure patients have clear red flag guidance post-procedure.
How SCS Fits Within a Comprehensive Pain Pathway
We rarely rely on a single intervention. Instead, we combine SCS or injections with rehabilitation, medication optimisation, sleep support, and psychological strategies. In our experience, patients who engage in active rehab and pacing alongside interventional care achieve more durable improvements in function.
Who is a candidate for SCS?
- Persistent neuropathic back and/or leg pain after spinal surgery (PSPS-T2)
- Pain refractory to medications, physiotherapy, and targeted injections
- Absence of surgically remediable compressive pathology
- Realistic goals and willingness to participate in a trial phase
Minimally Invasive Day Surgeries and Injections We Offer
For many, injections provide diagnostic clarity and relief, sometimes avoiding the need for implants. Examples include:
- Epidural steroid injections (lumbar or caudal) for radicular pain
- Medial branch blocks and radiofrequency ablation for facet-mediated pain
- Sacroiliac joint injections for posterior pelvic pain
- Trigger point injections for myofascial contributors
These are typically day-case procedures using imaging guidance, with return to light activity often within 24–48 hours.
What Do Independent Guidelines Say?
Major UK bodies acknowledge a role for SCS in neuropathic pain after spinal surgery when conservative measures fail. NICE guidance supports SCS for chronic neuropathic pain refractory to conventional management after a successful trial, provided multidisciplinary assessment is in place (see NICE TA159 and related updates at NICE). The systematic review above further supports moderate-quality evidence for pain and functional gains at six months, aligning with real-world practice.
Answers at a Glance: SCS for PSPS-T2
- Is SCS effective? Moderate-quality evidence shows meaningful pain and functional improvement at six months in selected patients.
- How quickly might I feel benefits? Many notice differences during the trial week; benefits are typically assessed over weeks to months.
- Is it a major surgery? No—SCS is usually a minimally invasive day-case or short-stay procedure.
- What are the main risks? Infection, lead migration, IPG site pain, and dural puncture—rates vary by centre and technique.
- Will I still need rehab? Yes—best outcomes pair SCS with targeted rehabilitation and self-management.
Our Perspective as a Pain Management Clinic in London
As clinicians, we’re encouraged by the growing evidence for SCS in PSPS-T2, especially where standard care has plateaued. We also remain pragmatic: careful selection, a transparent discussion of risks, and structured follow-up make the difference between a temporary lift and lasting change. With imaging-guided injections and minimally invasive day surgeries—including SCS trial and implantation—we tailor care to your goals: less pain, better function, and more good days.
Sources and Further Reading
Systematic review of SCS for PSPS-T2: PubMed | PMC | DOI
NICE guidance on SCS and chronic pain: NICE
Conclusion: Your Next Step
If you’re searching for a Pain Management Clinic in London for spinal chronic pain with minimally invasive day surgeries or injections, SCS and precision-guided interventions may offer a path forward—particularly if previous treatments haven’t delivered. We’ll help you weigh the evidence, understand the risks and benefits, and decide whether a trial makes sense for you. When done well, the results can be life-changing.
Best Pain Management Clinic in London with minimally invasive day-surgery
